Innate Pharma SA
Developing first-in-class antibody immunotherapies for cancer via the innate immune system.
IPHA | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 117 AVENUE DE LUMINY, 13009 MARSEILLE
- Website:
- https://www.innate-pharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Innate Pharma SA is a global, clinical-stage biotechnology company dedicated to developing innovative immunotherapies for cancer patients. The company's scientific approach is centered on leveraging the innate immune system to discover and develop first-in-class antibody-based therapeutics. Its product portfolio consists of a pipeline of clinical-stage assets, including proprietary programs like lacutamab and partnered assets such as monalizumab. Innate Pharma advances its pipeline through both independent development and strategic collaborations with major pharmaceutical partners, with the goal of improving clinical outcomes and providing new treatment options for patients with high unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Innate Pharma SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Innate Pharma SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Innate Pharma SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
